Neoplasms, Colorectal Recruiting Phase 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04080843Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC PatientsTreatment
NCT03280407NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal CancerTreatment